Akihiro Tamaki

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

This page only lists publications with an associated author ORCID identifier.

Publications

Kosuke Okuwaki, Masafumi Watanabe, Tsutomu Yoshida, Akihiro Tamaki, Tomohisa Iwai, Kai Adachi, Junro Ishizaki, Taro Hanaoka, Hiroshi Imaizumi, Mitsuhiro Kida, Chika Kusano
Efficacy of endoscopic ultrasound-guided tissue acquisition using stereo-microscopic on-site evaluation for possible comprehensive genome profile in patients with advanced pancreatic cancer. Journal of gastroenterology and hepatology 39 (4) (2024)
Kosuke Okuwaki, Masafumi Watanabe, Tsutomu Yoshida, Akihiro Tamaki, Tomohisa Iwai, Kai Adachi, Junro Ishizaki, Taro Hanaoka, Hiroshi Imaizumi, Mitsuhiro Kida, Chika Kusano
Efficacy of endoscopic ultrasound-guided tissue acquisition using stereo-microscopic on-site evaluation for possible comprehensive genome profile in patients with advanced pancreatic cancer. Journal of gastroenterology and hepatology 39 (4) (2024)
Kosuke Okuwaki, Masafumi Watanabe, Tsutomu Yoshida, Akihiro Tamaki, Tomohisa Iwai, Kai Adachi, Junro Ishizaki, Taro Hanaoka, Hiroshi Imaizumi, Mitsuhiro Kida, Chika Kusano
Efficacy of endoscopic ultrasound-guided tissue acquisition using stereo-microscopic on-site evaluation for possible comprehensive genome profile in patients with advanced pancreatic cancer. Journal of gastroenterology and hepatology (2024)
Akihiro Tamaki, Takuya Kato, Yasutaka Sakurai, Keita Sato, Kai Adachi, Masayoshi Tadehara, Taro Kogami, Masahiro Matsushita, Akiyoshi Hoshino, Itaru Sanoyama, Yoshiko Numata, Atsuko Umezawa, Masaaki Ichinoe, Masatoshi Ichihara, Chika Kusano, Yoshiki Murakumo
REV7 is involved in outcomes of platinum-based chemotherapy in pancreatic cancer by controlling the DNA damage response. Cancer science 115 (2) (2023)
Akihiro Tamaki, Takuya Kato, Yasutaka Sakurai, Keita Sato, Kai Adachi, Masayoshi Tadehara, Taro Kogami, Masahiro Matsushita, Akiyoshi Hoshino, Itaru Sanoyama, Yoshiko Numata, Atsuko Umezawa, Masaaki Ichinoe, Masatoshi Ichihara, Chika Kusano, Yoshiki Murakumo
REV7 is involved in outcomes of platinum-based chemotherapy in pancreatic cancer by controlling the DNA damage response. Cancer science 115 (2) (2023)
Akihiro Tamaki, Takuya Kato, Yasutaka Sakurai, Keita Sato, Kai Adachi, Masayoshi Tadehara, Taro Kogami, Masahiro Matsushita, Akiyoshi Hoshino, Itaru Sanoyama, Yoshiko Numata, Atsuko Umezawa, Masaaki Ichinoe, Masatoshi Ichihara, Chika Kusano, Yoshiki Murakumo
REV7 is involved in outcomes of platinum-based chemotherapy in pancreatic cancer by controlling the DNA damage response. Cancer science (2023)
Akihiro Tamaki, Takuya Kato, Yasutaka Sakurai, Keita Sato, Kai Adachi, Masayoshi Tadehara, Taro Kogami, Masahiro Matsushita, Akiyoshi Hoshino, Itaru Sanoyama, Yoshiko Numata, Atsuko Umezawa, Masaaki Ichinoe, Masatoshi Ichihara, Chika Kusano, Yoshiki Murakumo
REV7 is involved in outcomes of platinum-based chemotherapy in pancreatic cancer by controlling the DNA damage response. Cancer science 115 (2) (2023)